School of Medicine
Showing 1-100 of 301 Results
-
Deborah Kado
Professor of Medicine (Primary Care and Population Health) and, by courtesy, of Epidemiology and Population Health
BioDr. Kado is a board-certified, fellowship-trained doctor specializing in geriatrics. She serves as co-director of the Stanford Longevity Center. She is a professor of medicine and chief of research for the Geriatrics Section in the Department of Medicine, Division of Primary Care and Population Health. She is also the Director of the Geriatric Research, Education, and Clinical Center (GRECC) at VA Palo Alto Health Care System.
For each patient, Dr. Kado prepares a personalized care plan. Her objective is to help all individuals maintain the best possible health and quality of life as they age.
A special interest of Dr. Kado is bone health. She has conducted extensive research focused on osteoporosis and the related disorder hyperkyphosis.
Since joining the UCLA faculty in 2000, she has received continuous funding for her research from the National Institutes of Health (NIH).
She has over 100 peer-reviewed publications of her research findings in the Journal of Bone and Mineral Research, Osteoporosis International, Journal of Gerontology and Medical Sciences, Journal of Geriatric Oncology, Nature Communications, and other peer-reviewed journals.
In 2007, she defined hyperkyphosis as a new geriatric syndrome. Her discoveries in this field were first featured in the American College or Physician’s premier internal medicine journal Annals of Internal Medicine. Later, they also appeared in a dedicated chapter in UpToDate, the electronic resource providing evidence-based clinical decision support for doctors worldwide.
Prior to coming to Stanford, Dr. Kado practiced at UC San Diego where she started a dedicated osteoporosis clinic for patient care and research. She later broadened her research interests beyond musculoskeletal aging to study other aging-related topics such as the gut microbiome in older men and the effects of cancer treatments on aging in newly diagnosed breast cancer patients.
Dr. Kado is a California native. She trained at UCSF and UCLA. She also earned a Master of Science degree in epidemiology at the UCLA School of Public Health, sponsored by the John Hartford Foundation.
She is a member of the American Geriatrics Society, American Society of Bone and Mineral Research, Gerontological Society of America, The Endocrine Society, and other professional organizations. She co-chairs the NIH National Institute on Aging Workshop for the American Society of Bone and Mineral Research. She also participates in the Bone Health Working Group of the Society for Women’s Health Research. -
David Kahn, M.D.
Clinical Associate Professor, Surgery - Plastic & Reconstructive Surgery
Current Research and Scholarly InterestsCosmetic surgery and the study of changes associated with the aging appearance of the face.
1. Analysis and development of new procedures for aesthetic surgery of the face
2. Analysis of the changes the face undergoes with age in the bone and soft tissues
3. Analysis of techniques for rhinoplasty
4. Evaluation of optimal techniques for aesthetic and reconstructive breast surgery -
James Kahn
Professor of Medicine (General Medical Disciplines), Emeritus
Current Research and Scholarly InterestsMy initial research activities involved antiretroviral and novel therapeutic treatments of HIV infection, understanding elements of HIV pathogenesis associated with acute HIV infection and post exposure prevention. My most recent scholarly activities concentrate on working as a team to capitalize on the data stored in electronic medical records, HIV disease modeling and using electronic medical records for outcome research and developing a mentorship program for early career scientists.
-
Pooja Kakar
Member, Maternal & Child Health Research Institute (MCHRI)
Current Research and Scholarly InterestsAs a breastfeeding medicine physician, I am passionate about advocating for mother-infant dyads and supporting their breastfeeding journeys. Additionally, I am interested studying and addressing disparities in initiation and duration of breastfeeding, particularly in lower-resourced populations, by building and advancing community partnerships.
I am also interested in the use of digital health tools to advance upstream determinants of health in community-based settings. My current funded research projects include: 1) Providing a telehealth-based, weight control program to children with obesity from lower-income, racial and ethnic minority families (Gardner GOALS) and 2) Assessing and addressing disparities in healthy behaviors in families from under-resourced settings through the use of a secure, multilingual mobile neighborhood app (Our Voice: Beyond Clinic Walls). -
Anusha Kalbasi, M.D.
Associate Professor of Radiation Oncology (Radiation Therapy)
BioDr. Kalbasi is a board-certified radiation oncologist and physician-scientist at the Stanford Cancer Institute. He is also an associate professor of radiation oncology at Stanford Medicine and a project member of the Parker Institute for Cancer Immunotherapy.
In the clinic, Dr. Kalbasi specializes in the diagnosis and treatment of solid tumors, especially sarcoma and melanoma, with a focus on bringing new treatments to patients. This focus includes using advanced techniques in radiation oncology and cancer immunotherapy.
Dr. Kalbasi's NIH-funded laboratory studies the cancer-immune interface in various therapeutic contexts, including T cell therapy, cytokine therapy and innate immune agonism. The lab has described tumor cell-, T cell- and myeloid cell-intrinsic mechanisms of resistance to therapy and approaches to overcome therapy resistance. Dr. Kalbasi is also an experienced leader of clinical trials related to immunotherapy, T cell therapy and radiation therapy.
Prior to his arrival at Stanford Health Care, Dr. Kalbasi was assistant professor of radiation oncology in the David Geffen School of Medicine at UCLA and chief of sarcoma radiotherapy at the UCLA Jonsson Comprehensive Cancer Center. During his tenure, he was named a NextGen Star by the American Association of Cancer Research in recognition for excellence in cancer research.
Dr. Kalbasi’s work has been published in leading journals including Nature, Science Translational Medicine, JAMA Oncology, Lancet Oncology, Nature Cancer and Cancer Discovery. He has served as a peer reviewer for multiple prestigious journals, including the Proceedings of the National Academy of Sciences, Cell and the Journal of Clinical Investigation. He has also presented research to his peers at the American Association for Cancer Research and the American Institute of Chemical Engineers. -
Nathan Kalinowski, D.M.D.
Clinical Assistant Professor, Surgery - Plastic & Reconstructive Surgery
BioDr. Nathan Kalinowski is a Hospital Dentist and Clinical Assistant Professor in Dental Medicine and Surgery. He performs medically necessary dental clearance and extractions for patients preparing for cardiac surgery, radiation therapy, or organ transplantation. He also performs surgical treatment of infection and trauma to the teeth and supporting alveolar bone including reconstruction using dental implants.
-
Praveen Kalra
Clinical Associate Professor, Anesthesiology, Perioperative and Pain Medicine
BioDr. Praveen Kalra is Board Certified in Anesthesia and in Critical Care. He specializes in trauma, orthopedic, brain and spine surgery, urology, and cancer surgery. He was appointed Fellow of the American Society of Anesthesiology (FASA) in 2023. Appointed Medical Director of Sustainability for Stanford Healthcare in Dec 2023.
His professional interests include devising protocols for patient safety, informed consent, reducing the impact of anesthetics on the environment, addressing climate change by reducing green house gas emissions in the health care setting, resident education to emphasize evidence based safe care and mentoring medical students. He has been in practice for over 18 years.
Received the Inaugural Sustainability Ambassador Award in 2022 at SHC for removing Desflurane (anesthetic gas with highest global warming potential) from the OR and undertaking multiple initiatives such as creating a Green Team at SHC, an elective Green Rotation for residents, green curriculum video series and addressing plastic & biohazardous waste in the OR. Current projects are focused on decommissioning nitrous oxide pipelines in the OR. As Medical Director of Sustainability, I work on collaborating with experts, fostering clinician engagement in change management, and spearheading transformative initiatives.
Dr. Kalra completed his residency in Anesthesia from Harvard Medical School’s Beth Israel Deaconess Hospital and a fellowship in Critical Care from Johns Hopkins Hospital, Baltimore. -
Julia Kaltschmidt
Associate Professor of Neurosurgery
Current Research and Scholarly InterestsThe lab’s primary research interest is to understand how specific neuronal circuits are established. We use mouse genetics, combinatorial immunochemical labeling and high-resolution laser scanning microscopy to identify, manipulate, and quantitatively analyze synaptic contacts within the complex neuronal milieu of the spinal cord and the enteric nervous system.
-
Neil M. Kalwani
Clinical Instructor, Medicine - Cardiovascular Medicine
BioNeil Kalwani, MD, MPP is a Clinical Instructor in the Division of Cardiovascular Medicine and Director of Preventive Cardiology at the VA Palo Alto Health Care System. He attended college at Yale University and completed graduate degrees in medicine and public policy at Harvard University. He trained in internal medicine at Brigham and Women’s Hospital before arriving at Stanford in 2018 for fellowship in cardiovascular medicine, during which he served as Chief Fellow. He then completed a postdoctoral fellowship through the Stanford-AHRQ Health Services Research Training Program in the Department of Health Policy. His clinical focus is in general and preventive cardiology and echocardiography. He practices at the VA Palo Alto Health Care System and at Stanford Health Care.
Dr. Kalwani's research focuses on the evaluation of policies and care delivery innovations designed to improve the value of care for patients with cardiovascular disease. -
Afrin N. Kamal, MD MS
Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology
BioAfrin Kamal is a board-certified gastroenterologist, who trained at Washington University in internal medicine, Cleveland Clinic in gastroenterology/hepatology, and most recently Stanford University in esophageal and motility diseases. Afrin shares a clinical passion in esophageal motility diseases with an an overlapping interest in health services and outcomes research.
-
Robin Kamal MD MBA
Associate Professor of Orthopaedic Surgery
Current Research and Scholarly InterestsWrist and Elbow Injuries and Quality Measures in Orthopaedic Surgery
-
Aya Kamaya, MD
Professor of Radiology (Body Imaging)
Current Research and Scholarly InterestsHepatobiliary imaging
Hepatocellular carcinoma
Urologic imaging
Gynecologic imaging
Thyroid imaging
Novel ultrasound technologies
Perfusion CT imaging of abdominal tumors -
Neeraja Kambham
Professor of Pathology
Current Research and Scholarly InterestsDr. Kambham's research interests primarily involve medical diseases and transplantation pathology of the kidney and liver.
-
Komal Kamra
Clinical Professor, Anesthesiology, Perioperative and Pain Medicine
Current Research and Scholarly InterestsPediatric Cardiac Anesthesia
Transesophageal Echocardiography
Adult Congenital Heart Disease
Clinical Informatics -
Kathleen Kan
Clinical Assistant Professor, Urology
BioDr. Kathleen Kan is a fellowship-trained pediatric urologist with a clinical practice based at LPCH and additional outreach programs in the South Bay. Her current practice includes general, endoscopic and complex reconstructive procedures and a clinical counseling interest in kidney stone disease and differences in sexual differentiation. She currently serves as the Associate Program Director of the Urology residency program.
Her current research is focused on understanding why health elementary schoolchildren develop new bladder and bowel problems. -
Matthew Kanan
Professor of Chemistry
BioAssociate Professor of Chemistry Matthew Kanan develops new catalysts and chemical reactions for applications in renewable energy conversion and CO2 utilization. His group at Stanford University has recently developed a novel method to create plastic from carbon dioxide and inedible plant material rather than petroleum products, and pioneered the study of “defect-rich” heterogeneous electro-catalysts for converting carbon dioxide and carbon monoxide to liquid fuel.
Matthew Kanan completed undergraduate study in chemistry at Rice University (B.A. 2000 Summa Cum Laude, Phi Beta Kappa). During doctoral research in organic chemistry at Harvard University (Ph.D. 2005), he developed a novel method for using DNA to discover new chemical reactions. He then moved into inorganic chemistry for his postdoctoral studies as a National Institutes of Health Postdoctoral Research Fellow at the Massachusetts Institute of Technology, where he discovered a water oxidation catalyst that operates in neutral water. He joined the Stanford Chemistry Department faculty in 2009 to continue research into energy-related catalysis and reactions. His research and teaching have already been recognized in selection as one of Chemistry & Engineering News’ first annual Talented 12, the Camille Dreyfus Teacher-Scholar Award, Eli Lilly New Faculty Award, and recognition as a Camille and Henry Dreyfus Environmental Mentor, among other honors.
The Kanan Lab addresses fundamental challenges in catalysis and synthesis with an emphasis on enabling new technologies for scalable CO2 utilization. The interdisciplinary effort spans organic synthesis, materials chemistry and electrochemistry.
One of the greatest challenges of the 21st century is to transition to an energy economy with ultra-low greenhouse gas emissions without compromising quality of life for a growing population. The Kanan Lab aims to help enable this transition by developing catalysts and chemical reactions that recycle CO2 into fuels and commodity chemicals using renewable energy sources. To be implemented on a substantial scale, these methods must ultimately be competitive with fossil fuels and petrochemicals. With this requirement in mind, the group focuses on the fundamental chemical challenge of making carbon–carbon (C–C) bonds because multi-carbon compounds have higher energy density, greater value, and more diverse applications that one-carbon compounds. Both electrochemical and chemical methods are being pursued. For electrochemical conversion, the group studies how defects known as grain boundaries can be exploited to improve CO2/CO electro-reduction catalysis. Recent work has unveiled quantitative correlations between grain boundaries and catalytic activity, establishing a new design principle for electrocatalysis, and developed grain boundary-rich copper catalysts with unparalleled activity for converting carbon monoxide to liquid fuel. For chemical CO2 conversion, the group is developing C–H carboxylation and CO2 hydrogenation reactions that are promoted by simple carbonate salts. These reactions provide a way to make C–C bonds between un-activated substrates and CO2 without resorting to energy-intensive and hazardous reagents. Among numerous applications, carbonate-promoted carboxylation enables the synthesis of a monomer used to make polyester plastic from CO2 and a feedstock derived from agricultural waste.
In addition to CO2 chemistry, the Kanan group is pursuing new strategies to control selectivity in molecular catalysis for fine chemical synthesis. Of particular interest in the use of electrostatic interactions to discriminate between competing reaction pathways based on their charge distributions. This effort uses ion pairing or interfaces to control the local electrostatic environment in which a reaction takes place. The group has recently shown that local electric fields can control regioselectivity in isomerization reactions catalyzed by gold complexes. -
Beverley Kane
Adjunct Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioBeverley Kane, MD, was Board Certified in Family Medicine, then completed fellowships in Ob-Gyn (San Francisco Children's Hosptial) and Sports Medicine (London Univeristy). She has worked in the private practice of sports medicine; in medical informatics, specializing in doctor-patient communication (WebMD); and in stress management with her private practice, Horsensei Equine-Assisted Learning & THerapy (HEALTH). Her latest book, "Equine-imity--Stress Reduction and Emotional Self-Regulation in the Company of Horses," published 27 March 2021, can be seen at http://equine-imity.com/
-
Guson Kang
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioDr. Kang is an interventional cardiologist who specializes in the treatment of structural heart disease. He has expertise in complex coronary interventions, transcatheter aortic and mitral valve replacements, transcatheter mitral valve repair, left atrial appendage occlusion, PFO/septal defect closure, alcohol septal ablation, and paravalvular leak closure.
A Bay Area native, he graduated from Stanford University and obtained his medical degree at Yale University. He came back to Stanford to train in internal medicine, cardiology, and interventional cardiology before completing an advanced structural interventions fellowship at Ford Hospital. -
Ming Jeffrey Kao, PhD, MD
Clinical Associate Professor, Anesthesiology, Perioperative and Pain Medicine
Current Research and Scholarly Interests1. Patient-reported outcomes. Efficient, multi-feature item-response theory (IRT) based computerized adaptive testing (CAT) algorithm using item banks from PROMIS and NIH Toolbox
2. Activity monitoring. Novel analytic framework for physical activity monitoring in the context of pain.
3. Operations research. Multi-variable discrete and continuous optimization for Lean Hospital Management
4. National trends in pain medication prescription -
Peter Kao
Associate Professor of Medicine (Pulmonary and Critical Care Medicine)
Current Research and Scholarly InterestsOur research program has several active projects:
1.) Pulmonary Vascular Disease Simvastatin reversed experimental pulmonary hypertension, and is safe for treatment of patients. Blinded clinical trials of efficacy are in progress.
2.) Lung inflammation and regeneration (stem cells)
3.) Lung surfactant rheology and oxidative stress
4.) Gene regulation by RNA binding proteins, NF45 and NF90 through transcriptional and posttranscriptional mechanisms -
Michael S. Kapiloff, MD, PhD
Reinhard Family Professor, Professor (Research) of Ophthalmology and, by courtesy, of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsDr. Michael S. Kapiloff is a faculty member in the Departments of Ophthalmology and Medicine (Cardiovascular Medicine) and a member of the Stanford Cardiovascular Institute. Although Dr. Kapiloff was at one time a Board-Certified General Pediatrician, he is currently involved in full-time basic science and translational research. His laboratory studies the basic molecular mechanisms underlying the response of the retinal ganglion cell and cardiac myocyte to disease. The longstanding interest of his laboratory is the role in intracellular signal transduction of multimolecular complexes organized by scaffold proteins. Recently, his lab has also been involved in the translation of these concepts into new therapies, including the development of new AAV gene therapy biologics for the prevention and treatment of heart failure and for neuroprotection in the eye.
URL to NCBI listing of all published works:
http://www.ncbi.nlm.nih.gov/sites/myncbi/michael.kapiloff.1/bibliography/40252285/public/?sort=date&direction=descending
For more information see Dr. Kapiloff's lab website: http://med.stanford.edu/kapilofflab.html -
Katherine Kaplan
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsDr. Kaplan's research interests span four (often overlapping) domains: (1) pathophysiologic aspects of insomnia and hypersomnia in mood disorders, including mechanisms, correlates, and sequelae of these sleep disturbances; (2) behavioral interventions for sleep disturbances in adults and adolescents; (3) circadian and psychosocial factors impacting sleep in adolescence; and (4) machine learning approaches to big data.
-
Michael J. Kaplan, MD
Professor of Otolaryngology - Head & Neck Surgery at the Stanford University Medical Center, Emeritus
Current Research and Scholarly Interests1) New therapeutic approaches for head and neck cancer, including immune stimulation possibilities (IRX-2 protocol), integration of biological modifiers, and, eventually, genetic approaches.
2) Head and neck cancer stem cells: identification, characterization, control--in conjunction with the Irv Weissman and Michael Clarke labs in the Stem Cell Institute
3) Development of innovative surgical methods at the anterior cranial base -
Robert Kaplan
Adjunct Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsHealth services research
Studies on the cost and quality of health care
Health outcome measurement
Social determinants of health -
Daniel Kapp
Professor of Radiation Oncology, Emeritus
Current Research and Scholarly InterestsGynecologic malignancies; Rectal/and cancer; Breast Cancer; Hodgkin's disease; Hyperthermia; intraoperative radiation therapy; High dose rate radiation therapy; Predictive assays; Patterns of tumor spread; Health care finance.
-
Shanthi Kappagoda
Clinical Associate Professor, Medicine - Infectious Diseases
Current Research and Scholarly InterestsCompleted a Masters degree in Health Services Research in 2012. Research focused on using network models to develop a clinical research agenda for neglected tropical diseases.
-
Cynthia Kapphahn
Clinical Professor, Pediatrics - Adolescent Medicine
Current Research and Scholarly InterestsAccess to health care services for adolescents.
Confidentiality.
Mental Health Financing.
Eating disorders. -
Ioannis Karakikes
Associate Professor (Research) of Cardiothoracic Surgery
Current Research and Scholarly InterestsThe Karakikes Lab aims to uncover fundamental new insights into the molecular mechanisms and functional consequences of pathogenic mutations associated with familial cardiovascular diseases.
-
Amer Karam
Clinical Professor, Obstetrics & Gynecology - Gynecologic Oncology
BioDr. Amer Karam is a board-certified, fellowship-trained gynecologic surgeon and clinical professor in the Stanford Medicine Department of Obstetrics & Gynecology, Division of Gynecology Oncology. He specializes in gynecologic oncology, hospice and palliative care, hereditary gynecologic cancers, laparoscopic and robotic gynecologic surgery, and obstetrics and gynecology.
Dr. Karam attended medical school at the American University in Beirut. He completed his internship and residency at the Johns Hopkins Hospital in Baltimore, Maryland, before completing a fellowship in gynecologic oncology at the University of California Los Angeles and a fellowship in breast surgery at the Memorial Sloan-Kettering Cancer Center. Dr. Karam has a vested interest in minimally invasive and robotic surgery with a practice centered on this approach for the treatment of patients with gynecologic malignancy and complicated pelvic surgery. He is currently director of Robotic Surgery and Outreach in the Division of Gynecologic Oncology. -
Gloria M. Kardong MD, DLFAPA, DABPN
Adjunct Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioI attended Stanford University as an undergraduate, then returned to Stanford for my Psychiatry residency and Chief Residency. I then joined the Faculty in the Department of Psychiatry and Behavioral Sciences. I am an adjunct Clinical Associate Professor. I teach and supervise the residents in the program.
I am also on the Faculty of the Stanford Forensic Psychiatry Fellowship Program, where I teach and supervise post-graduate Fellows.
I have served an Examiner for the Medical Board of California and do Forensic Psychiatry/Expert Witness work for attorneys as part of my private practice for the past 15 years.
I have been in private practice for 35 years, including 15 years of virtual care. I am licensed in 10 states and can provide telepsychiatry services in all of those states.
Among my specialties are trauma; abuse; PTSD; women's health care-related issues, including pregnacy and post-partum issues, PMS, menopause and hormonal issues across the life span.
I also enjoy treating student health-related concerns and helping impaired professionals.
I treat all psychiatric problems for men, women, adolescents and couples. This includes anxiety, panic, bipolar disorder, ADHD, relationship issues and more. -
Mardi Karin, MD, FACS
Clinical Professor, Surgery - General Surgery
BioDr. Mardi R. Karin is a board certified surgeon with over 20 years of experience, specializing in breast surgery and is Clinical Professor of Surgery in Stanford University Department of Surgery, Section of Surgical Oncology. She was appointed the first Clinical Director of Breast Cancer Care at Stanford Cancer Center South Bay after the new cancer center opened and served in this role from 2016-2019. Dr. Karin specializes in the surgical treatment of breast diseases and cancer. In addition to providing outstanding care, her focus and leadership in breast cancer care includes improving coordinated care for breast cancer treatment both within the Cancer Center and the community.
Dr. Karin has extensive experience in breast surgery, including complex breast cancer skin and nipple sparing procedures in coordination with the plastic surgeon for immediate breast reconstruction and optimal appearance with excellent outcomes. She collaborates closely with Plastic and Reconstructive Surgery to provide the best options to patients, including Oncoplastics for optimal aesthetic appearance with breast conservation treatment, in addition to mastectomy with nipple sparing and immediate breast reconstruction. Her clinical research is focused on improving patient outcomes in different aspects of breast surgery, including nipple sparing mastectomy by utilizing MRI blood flow information to preserve important blood flow to reduce complications. She also is involved with advancing surgical techniques to decrease lymphedema rates after axillary lymph node dissection, with lymphatic preservation and possible LYMPHA procedure by the Plastic Reconstructive Microsurgeons. In addition, she works in close collaboration with Medical Oncology to offer the latest most advanced treatments for breast cancer. -
Jaya Karnani, MD
Adjunct Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Jaya Karnani practices family medicine in Bay Valley Medical Group’s Hayward office. She attended medical school at Kasturba Medical College in India and completed her residency at the Fort Wayne Medical Education Program in Indiana.
Dr. Karnani is board-certified by the American Board of Family Medicine. She speaks English and Hindi. Dr. Karnani joined Bay Valley Medical Group in 2009. In her spare time, she enjoys cooking, traveling, reading and watching movies. -
David Karpf
Adjunct Clinical Professor, Medicine - Endocrinology, Gerontology, & Metabolism
BioMy specialty within Endocrinology is Metabolic Bone Disease, including both osteoporosis and hypoparathyroidism, as well as other conditions including hyper- and hyo-calcemia, hypercalciuria, Paget's Disease, Osteogenesis Imperfecta, hypophosphatasia, and other metabolic bone diseases, as well as diabetes and thyroid diseases.
-
Krishna Govinda Kary (they/them)
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Krishna Kary (they/them) is a licensed psychologist who specializes in working with adolescents, adults, and couples within the LGBTQ+ community to address concerns related to depression, anxiety, sexuality, identity and interpersonal challenges. Dr. Kary received their PhD in Counseling Psychology from the Counseling, Clinical, and School Psychology program at the University of California, Santa Barbara. They received their MA and BS from Santa Clara University in Counseling and Psychology, respectively. Their clinical internship was completed at the University of California, Los Angeles Counseling and Psychological Services (CAPS) and their postdoctoral Gender and Sexual Identities fellowship at Stanford University CAPS. Dr. Kary serves patients through the THRIVE clinic at the Stanford School of Medicine and is emotion-focused, collaborative, and culturally-sensitive in their approach to psychotherapy. In addition to their interest in clinical care, they also enjoy supervision and training, teaching, and consultation related to gender inclusivity practices.
-
Karthikeshwar Kasirajan (Kasi)
Clinical Professor, Surgery - Vascular Surgery
BioDr. Kasirajan is a board-certified, fellowship-trained vascular surgeon. Also known as Dr. Kasi, he is a clinical professor of vascular surgery at Stanford University School of Medicine.
Dr. Kasirajan preserves limbs, facilitates access to dialysis, and helps his patients manage conditions such as aneurysms, varicose veins, thoracic outlet syndrome, and deep vein thrombosis. Many of his limb preservation patients smoke, have diabetes, or are experiencing renal failure. Dr. Kasirajan’s experience also centers around the treatment of aneurysms and prevention of strokes.
In all cases, his goal is to provide either noninvasive or minimally invasive management whenever possible. He performs open surgery only when it is the best option. Dr. Kasirajan treats many patients with stents and stent grafts, which can shorten hospital stays and recovery times.
Dr. Kasirajan (Kasi) receives referrals of patients from primary care physicians, nephrologists, podiatrists, cardiologists, woundcare specialists, diabetologists, neurologists, and other specialists. He welcomes referrals as early as possible, ideally before patients become symptomatic. A strong proponent of doing early screening for peripheral artery disease, Dr. Kasirajan advocates for the use of the ankle-brachial index (ABI) in routine physical examinations. When providers detect an imbalance between leg and arm blood pressure, Dr. Kasirajan can help create customized strategies to address the cause before the problem worsens.
In addition to offering excellent vascular care to the community, Dr. Kasirajan joined Stanford to continue pursuing his research interests. He has conducted research into advances in minimally invasive procedures for stroke prevention and for aneurysm management. His research has also focused on how to improve surgery outcomes to help patients suffering from peripheral vascular disease. Dr. Kasirajan has been the investigator in over 40 multicenter studies involving new stent graphs, thrombectomy catheters, and other advances in endovascular technology.
Dr. Kasirajan has made more than 100 presentations worldwide on minimally invasive vascular surgery techniques and preventive care in the vascular patient. He has spoken at multiple conferences including the Society for Vascular Surgery, Peripheral Vascular Society, and the South Asian American Vascular Society. He has earned numerous honors for his academic achievements, including the prestigious Alpha Omega Alpha award for medical student and resident education.
As the author of more than 120 journal articles, Dr. Kasirajan’s work has appeared in the Journal of Vascular Surgery, Endovascular Today, Pharmacogenomics Journal, Catheter Cardiovascular Intervention, and many other publications. He also has authored 20 book chapters in textbooks including Medical Management of the Surgical Patient 5th Edition, Advances in Phlebology and Venus Surgery Volume 1, Current Therapy in Vascular Surgery, Mastery of Surgery, and many more.
Dr. Kasirajan has served on the editorial boards of the Journal of Endovascular Therapy, Annals of Vascular Surgery, International Journal of Angiology, and other publications. -
Maya M. Kasowski
Assistant Professor of Medicine (Sean N Parker Center for Allergy and Asthma Research) of Pathology and, by courtesy, of Genetics
BioI am a clinical pathologist and assistant professor in the Departments of Medicine, Pathology, and Genetics (by courtesy) at Stanford. I completed my MD-PhD training at Yale University and my residency training and a post-doctoral fellowship in the Department of Genetics at Stanford University. My experiences as a clinical pathologist and genome scientist have made me passionate about applying cutting-edge technologies to primary patient specimens in order to characterize disease pathologies at the molecular level. The core focus of my lab is to study the mechanisms by which genetic variants influence the risk of disease through effects on intermediate molecular phenotypes.
-
Laura B. Kasper, PhD
Adjunct Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioI am psychologist and have been practicing psychotherapy for over 18 years. I have experience working with a diverse group of clients with respect to presenting concerns, gender, sexual orientation, and race/ethnicity.
Regardless of their background, the majority of my clients are highly intelligent and accomplished people who are interested in taking their personal and professional relationships to the next level, starting with themselves. My therapeutic approach blends my first-hand experience of the high-performing professional workplace with buddhist psychology and tools to offer support that is unrelentingly compassionate, direct, and powerful.
I have particular research and clinical expertise in authenticity with one's self and in relationships, interpersonal communication, and issues of sexual orientation, gender, and sexuality. My services include individual, couples, and group psychotherapy. I also do video counseling sessions with individuals and couples in CA, DC and VA, the places where I am licensed.
I earned my master’s and doctoral degrees from the University of Maryland’s Counseling Psychology program. I completed my internship and post-doctoral training, and was a Staff Psychologist at the The George Washington University Counseling Center for several years before starting my private practice. I am currently in the Interpersonal Dynamics Facilitator Training Program at Stanford University in the Graduate School of Business to become a small group facilitator for their popular elective, Interpersonal Dynamics.
I have been practicing Vipassana meditation for over fifteen years. I’ve spent eighty-five days on silent meditation retreats in that time, and have a mindfulness orientation to my work.
I am a member of the American Group Psychotherapy Association and the Northern California Group Psychotherapy Society, and the Northern California Society for Psychoanalytic Psychology. I am licensed and insured in California (PSY28532), Washington D.C. (PSY1000362) and Virginia (PSY0810004715). -
Michele Kastelein
Clinical Assistant Professor, Medicine - Vaden Health Center
Current Research and Scholarly InterestsAt Stanford University School of Medicine, one of our major goals is to translate research insights into practical advances that enhance and prolong life. We foster a two-way transfer of knowledge between research laboratories and patient-care settings. Our faculty, staff, postdoctoral scholars and students engage in interdisciplinary efforts to turn this knowledge into therapies that treat or prevent disease.
-
Tamiko Katsumoto
Clinical Associate Professor, Medicine - Immunology & Rheumatology
BioTamiko Katsumoto, MD, is a Clinical Associate Professor in the Division of Immunology and Rheumatology at Stanford University. She earned her MD from the University of California, San Francisco. She completed her internal medicine residency and rheumatology fellowship at UCSF, including a postdoc in the immunology lab of Dr. Arthur Weiss. Deeply committed to human and planetary health, she is passionate about educating her patients and colleagues on the merits of sustainable plant-rich diets as a strategy to both improve individual health and mitigate climate change and environmental degradation. She is fascinated by the impact of diet on inflammation and autoimmunity. She serves as the director of the Stanford Immune Related Toxicity Working Group, a multidisciplinary group which aims to improve the quality of care of cancer patients on immune checkpoint inhibitors. She has been investigating the impact of diet on immune-related adverse events. She is also intrigued by the relationship between cancer and autoimmune diseases, including diseases such as scleroderma and dermatomyositis, and the paraneoplastic manifestations of various cancers. She is involved in several clinical trials at Stanford and has spent time at Genentech, where she led several global clinical trials in immunology.
-
Daniel Katz
Instructor, Medicine - Cardiovascular Medicine
BioDaniel Katz is an Instructor of Medicine and an Advanced Heart Failure and Transplant Cardiologist. He completed internal medicine residency at Massachusetts General Hospital, general cardiology training at Beth Israel Deaconess Medical Center, and then joined Stanford in 2021 for his advanced heart failure training. Since medical school, his research has focused on identifying the various pathophysiologic patterns and mechanisms that lead to the heterogeneous syndrome of heart failure. His efforts leverage high dimensional data in many forms including clinical phenotypes, plasma proteomics, metabolomics, and genetics. He is presently engaged in analysis of multi-omic data from the Molecular Transducers of Physical Activity Consortium (MoTrPAC) and the NHLBI Trans-Omics for Precision Medicine (TOPMed) Program. His clinical interests include advanced heart failure, transplant cardiology, and mechanical circulatory support.
-
Maya Katz, MD
Clinical Associate Professor, Neurology & Neurological Sciences
BioDr. Katz is a board-certified neurologist who specializes in the treatment of Parkinson’s disease and other movement disorders. She is also a clinical associate professor of neurology at Stanford University School of Medicine.
In her clinical practice, she develops a comprehensive, compassionate treatment plan for every patient in her care. She excels at deep brain stimulation, neuromodulation, and other advanced treatment approaches. She also works closely with each patient’s caregivers and family members to help ensure optimal well-being and quality of life for all involved in the management of Parkinson’s disease, Huntington’s disease, Lewy body dementia, progressive supranuclear palsy, and other conditions.
Her research activities include serving as a co-investigator of the Parkinson’s Progression Markers Initiative funded by the Michael J. Fox Foundation. She is a site principal investigator for a National Institutes of Health-funded study of the application of palliative care to Parkinson’s disease. Previously, she was a co-investigator for studies of remote access to care for Parkinson’s disease and patient-centered outcomes in Parkinson’s disease, both funded by the National Parkinson Foundation.
Dr. Katz has earned many honors, including the ”Advancing Parkinson’s Therapies” conference award from the Parkinson’s Foundation and the “Fostering New Directions in Research” award from the Movement Disorders Society. She won scholarships from Weill Cornell Medical College, the Joseph Collins Foundation, and Anna E. Ray Robinson Education Fund.
She has presented her research findings at global meetings such as the International Parkinson and Movement Disorders Society and the International Palliative Care Society. She also has made presentations at national meetings of the American Academy of Neurology as well as regional conferences.
She has authored numerous articles on the topics of outpatient palliative care for Parkinson’s disease, caregiver burden in Parkinson’s disease, virtual visits for Parkinson’s disease, and diagnosis of cervical dystonia. Her work has appeared in journals including Neurology, Annals of Palliative Medicine, Contemporary Clinical Trials, Movement Disorders Clinical Practice, and Neurotherapeutics.
In addition, she is a reviewer for JAMA Neurology, the Journal of Neurological Sciences, Journal of Parkinson’s Disease, the brain imaging and stimulation section of Frontiers in Human Neuroscience, and Parkinsonism and Related
Disorders.
Dr. Katz is a member of the American Academy of Neurology, International Parkinson and Movement Disorders Society, Parkinson’s Foundation, Parkinson’s Study Group, American Academy of Hospice and Palliative Medicine, and American Telemedicine Association. She also is an invited speaker at community support groups for people with Parkinson’s disease. -
Laurence Katznelson, MD
Professor of Neurosurgery and of Medicine (Endocrinology)
Current Research and Scholarly InterestsDr. Katznelson is an internationally known neuroendocrinologist and clinical researcher, with research expertise in the diagnosis and management of hypopituitarism, the effects of hormones on neurocognitive function, and the development of therapeutics for acromegaly and Cushings syndrome, and neuroendocrine tumors. Dr. Katznelson is the medical director of the multidisciplinary Stanford Pituitary Center, a program geared for patient management, clinical research and patient education
-
David Kauvar
Clinical Professor, Surgery - Vascular Surgery
BioDavid Kauvar, MD, MPH is an academic vascular surgeon who received his undergraduate medical education on active duty in the US Army at the Uniformed Services University of the Health Sciences in Bethesda, Maryland. He completed his residency in general surgery at Brooke Army Medical Center in San Antonio, Texas, a surgical research fellowship at the United States Army Institute for Surgical Research, and a clinical fellowship at the University of Utah. His 24-year career as a wartime and vascular surgeon culminated with his retirement in 2022. During his tenure in the military, Dr. Kauvar was a respected surgical educator and became an academic leader in the fields of military and vascular trauma. He earned a Master of Public Health degree from the University of North Texas and was inducted into the Order of Military Medical Merit for his contributions to military medicine.
Dr. Kauvar has served as a general surgery residency associate program director for research and as a residency program director, chair of an institutional review board, and chief of a vascular surgery service. He commanded a combat surgical unit in Afghanistan and led two multimillion-dollar Department of Defense combat casualty care research labs. He has authored over eighty peer-reviewed publications and numerous textbook chapters, has presented research at dozens of national and international surgical meetings and has been invited to speak internationally about vascular trauma as an acknowledged expert in the field.
Dr. Kauvar is now Clinical Professor of Surgery in the Division of Vascular Surgery at Stanford University School of Medicine with his primary clinical responsibilities at Santa Clara Valley Medical Center in San Jose, California. He is married and has one son. -
Makoto Kawai
Clinical Associate Professor, Psychiatry and Behavioral Sciences - Sleep Medicine
BioI am a physician scientist in the field of sleep medicine in aging and brain function. Using combined polysomnogram and novel neuroimaging technology, I aim to identify potential sleep biomarkers to investigate the mechanism of progression from normal aging to Mild Cognitive Impairment (MCI) or dementia. I also investigate the impact of sleep on cognitive/affective function or behavior abnormality in various neurodevelopmental and neurodegenerative disorders.
-
Masataka Kawana
Assistant Professor of Medicine (Cardiovascular Medicine)
BioDr. Kawana joined the Advanced Heart Failure and Transplant Cardiology group in 2018. He completed his internal medicine, cardiovascular medicine, and heart failure training at Stanford. He also completed a postdoctoral research fellowship under Dr. James Spudich in the Department of Biochemistry. He sees advanced heart failure patients in the clinic and attends CCU/heart failure service, and post-heart transplant and MCS service. His research interests are in the fundamental mechanism of inherited cardiomyopathies, and he studies the effect of gene mutation on the cardiac sarcomere function using cutting-edge biochemical and biophysical approaches, which would lead to the development of novel pharmacotherapy that directly modulates cardiac muscle protein. He is involved in multiple clinical trials for pharmacotherapy in inherited cardiomyopathy and also conducting a device study in heart failure.
-
Mark A. Kay, M.D., Ph.D.
Dennis Farrey Family Professor of Pediatrics, and Professor of Genetics
Current Research and Scholarly InterestsMark A. Kay, M.D., Ph.D. Director of the Program in Human Gene Therapy and Professor in the Departments of Pediatrics and Genetics. Respected worldwide for his work in gene therapy for hemophilia, Dr. Kay and his laboratory focus on establishing the scientific principles and developing the technologies needed for achieving persistent and therapeutic levels of gene expression in vivo. The major disease models are hemophilia, hepatitis C, and hepatitis B viral infections.
-
Debra Lee Kaysen
Professor of Psychiatry and Behavioral Sciences (Public Mental Health & Population Sciences)
Current Research and Scholarly InterestsMuch of my current research focus is on the development of testing of accessible, scaleable, and effective treatments for trauma-related disorders and related comorbidities (e.g. substance use disorders, HIV, mood disorders). This work has focused on addressing trauma-related disorders especially in underserved populations and settings. This includes research in rural communities, with Native American communities, and with sexual minorities. My research has had a strong impact on building an evidence base on adaptations of psychotherapies for PTSD and substance use disorders for diverse populations both within and outside the United States. Our findings demonstrate that complex cognitive behavioral psychotherapies like Cognitive Processing Therapy can be culturally adapted and delivered in challenging settings (conflict settings, high poverty environments) with significant and lasting change in PTSD, depression, and functioning. This has led to work adapting CPT for diverse populations within the United States (rural Native Americans, urban Latinos) and outside of it (Iraq, DRC). Other research has focused on treatment for PTSD/SUD. My research has also found support for the use of brief telehealth interventions to build treatment engagement and to reduce drinking among trauma-exposed populations. In addition, my work has been critical in testing the feasibility of novel trauma-focused interventions for use by those with PTSD and SUD, thus paving the road for more rigorous research studies.
Current PI'ed research studies include: 1) developing and evaluating a brief motivational interviewing intervention designed to increase treatment-seeking among military personnel with untreated PTSD; a two-arm randomized comparative effectiveness trial to evaluate prevention of HIV/STI sexual risk behavior by addressing PTSD through Narrative Exposure Therapy or substance use through Motivational Interviewing among Native American men and women with PTSD; and 3) a comparison of outcomes among patients randomized to initially receive pharmacotherapy or Written Exposure Therapy delivered in primary care as well as comparing outcomes among patients randomized to treatment sequences (i.e., switching and augmenting) for patients who do not respond to the initial treatment. -
Electron Kebebew, MD, FACS
Harry A. Oberhelman, Jr. and Mark L. Welton Professor
Current Research and Scholarly InterestsDr. Kebebew’s translational and clinical investigations have three main scientific goals: 1) to develop effective therapies for fatal, rare and neglected endocrine cancers, 2) to identify new methods, strategies and technologies for improving the diagnosis and treatment of endocrine neoplasms and the prognostication of endocrine cancers, and 3) to develop methods for precision treatment of endocrine tumors.
-
Corey Keller, MD, PhD
Assistant Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)
Current Research and Scholarly InterestsThe goal of my lab is to understand the fundamental principles of human brain plasticity and build trans-diagnostic real-time monitoring platforms for personalized neurotherapeutics.
We use an array of neuroscience methods to better understand the basic principles of how to create change in brain circuits. We use this knowledge to develop more effective treatment strategies for depression and other psychiatric disorders. -
Jennifer Keller
Clinical Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly Interestsinterpersonal violence and abuse prevention; empowerment of women; cognitive and affective information processing in depression; clinical, biological, and neuropsychological aspects of depression; South Asian mental health
-
Kevin Kelley
Assistant Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology)
BioAs a neuroscientist and psychiatrist, I am motivated by how little we understand about the pathophysiology of psychiatric disorders and hope that further knowledge will help to alleviate the ongoing distress of many of our patients. My research program leverages computational genomics, human brain cellular models, and molecular neuroscience techniques to understand the cellular and molecular mechanisms of human brain development and how dysfunction in these processes lead to psychiatric disorders.
-
Joan Kendig
Professor of Biology in the Department of Anesthesia, Emeritus
Current Research and Scholarly InterestsMy laboratory tries to find out how pharmacologic agents used in the practice of anesthesia (general anesthetic and analgesic agents) lead to therapeutically desireable endpoints including unconsciousness, immobility and absence of pain. The old idea that general anesthetics are uniformly non-specific "membrane stabilizers" is giving way to a new realization that these agents exert specific actions on particular ion channels and intracellular signalling systems.
-
Vanessa Kennedy
Assistant Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
BioDr. Kennedy is a board-certified hematologist and medical oncologist who specializes in the treatment of myeloid malignancies, including acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and myelofibrosis (MF). She is an Assistant Professor in the Department of Medicine, Division of Blood and Marrow Transplantation & Cellular Therapy, at Stanford University School of Medicine.
Dr. Kennedy conducts extensive research, ranging from interventional clinical trials to epidemiology studies. She also has expertise in the use of clinical informatics and bioinformatics in improving patient outcomes. Her work has been supported by grant funding from the American Society of Clinical Oncology, the American Society of Hematology, and the Chan-Zuckerberg Foundation. Her goal is to understand and improve outcomes in patients with myeloid malignancies. -
John Kerner
Professor of Pediatrics (Gastroenterology), Emeritus
Current Research and Scholarly InterestsI am interested in pediatric nutritional support and have experience evaluating new enteral and parenteral products especially for the neonate (I studied a "new" I.V. fat product for Abbott; I participated in a multicenter trial of a formula with fish oil in it for neonates with Mead Johnson and a multicenter trial of a new human milk fortifier for Wyeth).
-
Andrew Kesselman
Clinical Assistant Professor, Radiology
Current Research and Scholarly InterestsCurrently studying the role of interventional therapies in caval filtration, venous thromboembolism and primary and metastatic hepatic malignancies.
-
Terence Ketter
Professor of Psychiatry and Behavioral Sciences (Psychopharmacology), Emeritus
Current Research and Scholarly InterestsThe use of brain imaging methods for understanding the neurobiology of mood disorders and to target treatments for patients with bipolar disorders. Research in the use of novel medications and combinations of medications in the treatment of bipolar disorders. Research on the development and course of bipolar disorder in late adolescence and young adulthood, particularly in college students, and links between creativity, temperament, and mood disorders.
-
Kian Keyashian
Clinical Associate Professor, Medicine - Gastroenterology & Hepatology
BioThe management of inflammatory bowel disease continues to evolve, with the introduction of biologic and small molecule therapies and new goals of treatment, with an emphasis on healing the bowel. My career goal since my graduation from IBD fellowship in 2012 has been to improve the outcomes and quality of life of patients with inflammatory bowel disease. In line with these goals, my research has focused investigating new noninvasive diagnostic test, finding factors early in the disease course that might predict a more aggressive disease course and need for different therapies, and investigating new promising effective medications with less side effects.
-
Khizer Khaderi MD, MPH
Clinical Associate Professor, Ophthalmology
BioDr. Khizer Khaderi is a Clinical Associate Professor at the Byers Eye Institute at Stanford University. Khaderi is the Founding Director of the Stanford Human Perception Laboratory (HPL) and the Stanford Vision Performance Center (VPC). He also serves as faculty at the Stanford Institute for Human-Centered AI and the Wu Tsai Human Performance Alliance (HPA)
Khaderi is a renowned Neuro-Ophthalmic surgeon, technologist and futurist. Dr. Khaderi is pioneering the field of Symbiotics, defined as the convergence of human science + computer science to design and develop human-centric technologies. Khaderi has extensive domain expertise in artificial intelligence (AI), spatial computing (virtual reality (VR), augmented reality (AR), mixed reality (MxR)), wearables, gaming, IoT, Web3, applied neuroscience, human factors, and human-machine interfaces/interaction. His research interests include developing personalized human intelligent systems based on the human brain and sensory systems, developing technologies to optimize human performance, and combining biological and computational principles to expand our capabilities in research, clinical practice, and everyday life. Dr. Khaderi's approach to advance research interests and develop practical applications for everyday use is building technology, companies and collaborative partnerships across academia and industry.
Dr. Khaderi’s experience across industry sectors include consumer electronics, gaming, retail, life science, sports/Esports health care, Pharma, e-commerce, to name a few. He has developed novel technologies in these areas, and generated multiple invention patents. Selected as a “40 under 40”, he contributed to President Obama’s Council of Advisors on Science and Technology regarding vision technology and the aging population. He also advises multiple companies, venture firms and organizations including the Global Esports Federation, Magic Leap, Riot Games, Intel, Activision, Unity, Epic Games, Google, FB, Microsoft, Apple, NBA, Aerie Pharma, the World Health Organization, and the World Bank.
